Is ACADIA Pharmaceuticals Inc. (ACAD) halal? Doubtful. Based on AAOIFI screening, ACADIA Pharmaceuticals Inc. passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 78/100 (Grade: B+).
ACAD — Is ACADIA Pharmaceuticals Inc. Halal?
DoubtfulACADIA Pharmaceuticals Inc.
$20.89
-2.93%
About ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Sector: Healthcare · Industry: Biotechnology
Why This Stock Is Doubtful
- Interest-bearing deposits are 26.9% of market cap — only 3.1 points below the 30% limit
Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.
Shariah Compliance Status
Based on AAOIFI screening standards
Good
Good compliance with minor concerns
Business Activity Screen
PassedChecks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)
Financial Ratio Screen
PassedFinancial ratios must be below AAOIFI thresholds
Compliance History
Doubtful — unchanged since May 2026.
No status changes recorded since we began tracking.
Tracked since May 2026. Updates automatically on each re-screen.
Purify Your ACAD Dividends
Calculate your purification amount for ACAD dividends based on AAOIFI standards.
Financial Overview
Market Cap
3.6B
Price
$20.89
Sector
Healthcare
Industry
Biotechnology
More Healthcare Stocks
Track ACAD and 10,000+ stocks with AI insights
Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.
Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.